Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.38 |
| ▸ | FURIN | P09958 | 9/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | Q9HBH1 | 1/20 | 0.37 | |
| ▸ | CALCRL | Q16602 | 1/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 2/20 | 0.34 |
| ▸ | NMT2 | O60551 | 1/20 | 0.34 |
| ▸ | NMT1 | P30419 | 1/20 | 0.34 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25360798 | 0.91 | FURIN (0.37) | CTSLFURINROCK2 | |
| SCHEMBL25361709 | 0.91 | FURIN (0.37) | CTSLFURINROCK2 | |
| SCHEMBL25359008 | 0.90 | CTSL (0.38) | CTSLKLKB1FURINROCK2PDF | |
| SCHEMBL20541625 | 0.86 | CASP1 (0.35) | — | |
| SCHEMBL25359743 | 0.86 | CALCRL (0.51) | ROCK2CALCRLPLGSSTR3 | |
| SCHEMBL25363467 | 0.86 | CALCRL (0.51) | ROCK2CALCRLPLGSSTR3 | |
| SCHEMBL26026944 | 0.85 | SIRT5 (0.38) | CTSLKLKB1FURINROCK2 | |
| SCHEMBL25350530 | 0.84 | FURIN (0.35) | FURIN | |
| SCHEMBL28650727 | 0.84 | FURIN (0.39) | CTSLKLKB1FURINROCK2 | |
| SCHEMBL28580456 | 0.84 | FURIN (0.39) | CTSLKLKB1FURINROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4103236-B1 | FOLATE RECEPTOR TARGETED NANOPARTICLE DRUG CONJUGATES AND USES THEREOF | ELUCIDA ONCOLOGY INC (US) | 2023-08-16 | — | — | EP | disclosed |